FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.…
News
FDA approves new cholesterol-lowing drug
On July 24, the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of…
FDA approves new device for treating obesity
On July 28, the U.S. Food and Drug Administration (FDA) approved the ReShape Integrated Dual Balloon System to treat obesity in adults. Read more.
FDA authorizes prosthesis for above-the-knee amputations
On July 16, the U.S. Food and Drug Administration (FDA) authorized use of the first prosthesis marketed in the U.S. for adults who have…
FDA approves new drug for schizophrenia and new drug for lung cancer
On July 13, the U.S. Food and Drug Administration (FDA) approved Rexulti (brexpiprazole) to treat adults with schizophrenia and as an add-on treatment to…
FDA approves new drug for cystic fibrosis
On July 2, the U.S. Food and Drug Administration (FDA) approved Orkambi (lumacaftor 200 mg/ivacaftor 125 mg) for the treatment of cystic fibrosis (CF)…
FDA approves antiplatelet drug for use during PCI
On June 22, the U.S. Food and Drug Administration (FDA) approved Kengreal (cangrelor), an I.V. antiplatelet drug, for use in adults undergoing undergoing percutaneous…
FDA approves artificial heart valve
On June 17, the U.S. Food and Drug Administration (FDA) approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with aortic valve stenosis.…
FDA mandates removal of trans fats in processed foods
On June 16, the U.S. Food and Drug Administration (FDA) announced that food manufacturers will have 3 years to remove partially hydrogenated oils, the…
FDA issues alert for facial soft tissue fillers
On May 28, the U.S. Food and Drug Administration (FDA) issued an alert about the possibility of rare, but serious, injuries that may occur…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in…
FDA approves new cholesterol-lowing drug
On July 24, the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new…
FDA approves new device for treating obesity
On July 28, the U.S. Food and Drug Administration (FDA) approved the ReShape Integrated Dual Balloon System to treat obesity in adults.…
FDA authorizes prosthesis for above-the-knee amputations
On July 16, the U.S. Food and Drug Administration (FDA) authorized use of the first prosthesis marketed in the U.S. for adults…
FDA approves new drug for schizophrenia and new drug for lung cancer
On July 13, the U.S. Food and Drug Administration (FDA) approved Rexulti (brexpiprazole) to treat adults with schizophrenia and as an add-on…
FDA approves new drug for cystic fibrosis
On July 2, the U.S. Food and Drug Administration (FDA) approved Orkambi (lumacaftor 200 mg/ivacaftor 125 mg) for the treatment of cystic…
FDA approves antiplatelet drug for use during PCI
On June 22, the U.S. Food and Drug Administration (FDA) approved Kengreal (cangrelor), an I.V. antiplatelet drug, for use in adults undergoing…
FDA approves artificial heart valve
On June 17, the U.S. Food and Drug Administration (FDA) approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with aortic…
FDA mandates removal of trans fats in processed foods
On June 16, the U.S. Food and Drug Administration (FDA) announced that food manufacturers will have 3 years to remove partially hydrogenated…
FDA issues alert for facial soft tissue fillers
On May 28, the U.S. Food and Drug Administration (FDA) issued an alert about the possibility of rare, but serious, injuries that…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.